| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |